This artice is free to access.
In this podcast, we talk to Dr Sunil Verma about the evolution of HER2 as a therapeutic target in breast cancer, and about how targeted therapy has revolutionized breast cancer treatment. We also discuss new agents in clinical development and the ways in which advances in treating HER2-positive breast cancer can be used to inform treatment decisions in other areas of medicine. The podcast for this interview is available at: http://media.biomedcentral.com/content/movies/supplementary/SunilVerma-QandA.mp3.
Verma, S. (2014). Advances in treating HER2-positive breast cancer: An interview with Sunil Verma. BMC Medicine, 12(1). https://doi.org/10.1186/s12916-014-0129-y